Immune cells, notably Foxp3 + Tregs and IL-10 + regulatory B cells (Bregs), also serve as sources, with the former inhibiting anti-tumor immunity in MM and the latter reducing T cell proliferation [14, 51, 53, 54]. The gene discussed is IL10; the disease is Miyoshi myopathy.